Substance Use Disorder
For patients with comorbid substance use disorder and anxiety, adding cognitive behavioral therapy for anxiety disorders to typical treatment for substance abuse disorders may help prevent the return of symptoms.
Causes of death in the year after a nonfatal opioid overdose were often related to substance use disorders, as well as to a range of mental health and medical conditions.
While many treatments for substance use disorder are not evidence based, several evidence-based approaches have shown effectiveness in court-mandated treatment settings.
Based on current evidence, there is a strong consensus that medication-assisted treatment is recommended over detoxification in the treatment of opioid use disorder during pregnancy.
Recent physician-prescribed opioids represent the main source of provenance of the drug in individuals age ≥65 years who misuse them.
April 28, 2018 is National Prescription Drug Take Back Day.
New findings suggest that DSM-5 criteria may apply to betel use disorder and offer opportunities to advance the study and understanding of substance use disorder in general.
The proposal addresses inappropriate ICD-10-CM coding options for withdrawal from opioids, sedatives, or stimulants.
Between 2005 and 2014, the prevalence of chronic conditions increased across all segments of the childbearing population, including substance use disorder.
A motivational interviewing intervention delivered by trained counselors reduced the rate of opioid overdoses in participants with opioid use disorder.
New pharmacotherapies in combination with psychotherapy and counseling have proven effective in preventing relapse.
Quetiapine-XR may be effective in reducing substance abuse in patients with comorbid bipolar disorder.
Substance Use Disorder is a chronic medical condition, and should be treated like one.
A targeted form of CBT is effective in treating chronic pain and substance use disorder in veterans with hepatitis C virus infection.
Short-term memory loss may be yet another price of America's opioid addiction epidemic.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Predicting Pain Chronicization After Spine Surgery
- Chronic Low Back Pain Levels Vary Between Sex and Race
- FDA Approval of Medication With a Digital Monitoring System: Major Breakthrough or "Brave New World"?
- Errors in Clinical Notes Generated by Speech Recognition Are Not Uncommon
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?